Exchange proteins directly activated by cAMP induce the proliferation of rat anterior pituitary GH3 cells via the activation of extracellular signal-regulated kinase

Biochem Biophys Res Commun. 2017 Apr 1;485(2):355-359. doi: 10.1016/j.bbrc.2017.02.075. Epub 2017 Feb 17.

Abstract

Cyclic adenosine 3'-5'-monophosphate (cAMP) plays a crucial role in regulating pituitary cell proliferation and hormone synthesis. Recent evidence suggests that exchange proteins directly activated by cAMP (Epacs) may mediate the effects of cAMP. Here we used rat anterior pituitary GH3 cells as the experiment model to demonstrate that forskolin increased the proliferation of GH3 cells and the phosphorylation of ERK1/2, and these effects were inhibited by PKA or Epac inhibitors. Epac activator 8-pCPT-2'-O-Me-cAMP increased GH3 cell proliferation and this was blocked by ESI-09, an Epac inhibitor. In contrast, forskolin-induced phosphorylation of CREB was unaffected by Epac inhibition. Notably, increased phosphorylation of ERK1/2 was correlated with increased cyclin D3 expression in GH3 cells. Furthermore, knockdown of Epac as well as B-Raf and MEK inhibitors blocked 8-pCPT-2'-O-Me-cAMP induced proliferation of GH3 cells and the phosphorylation of ERK1/2. In conclusion, our study suggests that Epac mediates cAMP induced pituitary cell proliferation via B-Raf and MAPK dependent mechanism.

Keywords: B-Raf; ERK; Epac; Pituitary cells; Proliferation.

MeSH terms

  • Animals
  • Blotting, Western
  • Butadienes / pharmacology
  • Cell Line, Tumor
  • Cell Proliferation*
  • Colforsin / pharmacology
  • Cyclic AMP / analogs & derivatives
  • Cyclic AMP / pharmacology
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Cyclin D3 / metabolism
  • Enzyme Activation / drug effects
  • Enzyme Inhibitors / pharmacology
  • Guanine Nucleotide Exchange Factors / antagonists & inhibitors
  • Guanine Nucleotide Exchange Factors / genetics
  • Guanine Nucleotide Exchange Factors / metabolism*
  • Hydrazones / pharmacology
  • Isoquinolines / pharmacology
  • Isoxazoles / pharmacology
  • MAP Kinase Kinase 1 / antagonists & inhibitors
  • MAP Kinase Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 1 / metabolism*
  • Mitogen-Activated Protein Kinase 3 / metabolism*
  • Nitriles / pharmacology
  • Phosphorylation / drug effects
  • Pituitary Gland / drug effects
  • Pituitary Gland / metabolism
  • Pituitary Gland / pathology
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors
  • Proto-Oncogene Proteins B-raf / metabolism
  • RNA Interference
  • Rats
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sulfonamides / pharmacology

Substances

  • 3-(5-tert-butylisoxazol-3-yl)-2-((3-chlorophenyl)hydrazono)-3-oxopropionitrile
  • 8-(4-chloro-phenylthio)-2'-O-methyladenosine-3'-5'-cyclic monophosphate
  • Butadienes
  • Cyclin D3
  • Enzyme Inhibitors
  • Guanine Nucleotide Exchange Factors
  • Hydrazones
  • Isoquinolines
  • Isoxazoles
  • Nitriles
  • Rapgef3 protein, rat
  • Rapgef4 protein, rat
  • Sulfonamides
  • U 0126
  • Colforsin
  • Cyclic AMP
  • Braf protein, rat
  • Proto-Oncogene Proteins B-raf
  • Cyclic AMP-Dependent Protein Kinases
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • MAP Kinase Kinase 1
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide